We are 4-(1-Methyl-5-nitro-1H-benzimidazol-2-yl)butanoic acid CAS:31349-48-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Related News: China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.81090-53-1 Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.3-Bromo-2-Fluoroaniline CAS:58534-95-5 Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.2-(2-amino-4-bromophenyl)-5-bromoaniline Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.
Product Name | |
---|---|
Linocaine Hydrochloride Cas:6108-05-0 | View Details |
4-Amino-2,5-Difluorobenzoic Acid | View Details |
2-[2-(4-fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxopentanoic Acid Phenylamide Cas:125971-96-2 | View Details |